Fragmented subspecialty care and underbuilt survivorship pathways risk overwhelming primary care as the survivor population ...

Meena Bansal, MD, discusses the evolving MASH pipeline and why precision phenotyping, biomarkers, and cardiovascular outcomes ...

Fee-for-service beneficiaries had higher BGP use than Medicare Advantage (25.8% vs 24.6%; AOR 1.08), indicating payer ...

Life sciences leaders cite similar distress drivers and expect IRA-linked pricing pressure; global pricing dynamics, competitive intensity, and payer/PBM leverage threaten pricing power while AI ROI ...

Effective compliance now spans transaction eligibility, OPAIS synchronization, Medicaid exclusion validation, cost-report ...

Full results from the pivotal B-Well 1 and B-Well 2 phase 3 trials confirm that bepirovirsen delivers statistically significant functional cure rates in chronic hepatitis B. Bepirovirsen (GSK/Ionis ...

Pathogenic variants were present in 0.5% (GMC) to 0.9% (UKBB), with MITF E318K accounting for most carriers and reaching 0.8% in UKBB. Enrichment exceeded a 2.5% testing threshold in high-risk ...

Outpatient visits for serious mental illness rose about 3.1%–3.5% after expirations, without significant changes in overall ...

Weekly AHB-137 300 mg for 16 weeks achieved HBV DNA <10 IU/mL in 100% and complete response in 68% at end of treatment without concomitant nucleos(t)ide analogues. Baseline HBsAg stratified outcomes, ...

International benchmarking across coverage/access, affordability, equity, and delivery places the US as the highest spender, far exceeding Switzerland ($7,927 per capita), without commensurate outcome ...

Age-stratified outcomes favored adolescents (48.6% SALT ≤20) versus adults (21.9%), plausibly related to shorter disease duration, shorter current episode, and greater follicular regenerative capacity ...

Sequencing CAR T-cell therapy versus bispecific antibodies in myeloma increasingly hinges on MRD depth, transplant candidacy, ...